Weeks Five Through Twelve This phase represents the most active period for both compounds
We cannot see you if you are driving or in an unsafe Medical Records: If you have any relevant medical records, prescriptions, or a list of medications you are currently taking, please have them handy for reference
GLP-1 medications commonly cause nausea, vomiting, diarrhea, and other gastrointestinal effects, particularly when starting treatment or increasing doses
ClinicalTrials.gov: NCT04881760), participants receiving the highest dose of retatrutide demonstrated mean body weight reductions of approximately 24% over 48 weeks among the most significant weight-loss outcomes observed in pharmacological trials to date
Pop the plastic protective caps off both the Retatrutide vial and the Bacteriostatic Water vial
GIPR agonism in the context of a functioning GLP-1R signal produces synergistic effects that neither pathway achieves alone